1 / 8

In Vitro Diagnostics (IVD) Quality Control Products Market Is Expected to Reach $1,052 Million, Globally, by 2022

In Vitro Diagnostics (IVD) Quality Control Products Market Report, published by Allied Market Research, forecasts that the global market was valued at $823 million in 2015, and is expected to reach $1,052 million by 2022, registering a CAGR of 3.5% during the forecast period 2016 - 2022. The serum/plasma based controls accounted for the largest share in the quality controls market in 2015, and is estimated to grow at the fastest CAGR of 4.1% from 2016 to 2022.<br>

srushtih123
Download Presentation

In Vitro Diagnostics (IVD) Quality Control Products Market Is Expected to Reach $1,052 Million, Globally, by 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opportunity Analysis and Industry Forecast, 2016-2023 In Vitro Diagnostics (IVD) Quality Control Product Market Worldwide: Market Dynamics and Trends, Efficiencies Forecast 2023 Global Opportunity Analysis and Industry Forecast, 2014-2022

  2. In Vitro Diagnostics (IVD) Quality Control Product Market “The growth of the global IVD quality control products market is propelled by increase in adoption of multianalyte third party quality controls, She further added, serum/plasma-based controls products are popular due to their high stability and long self life.”

  3. In Vitro Diagnostics (IVD) Quality Control Product Market In Vitro Diagnostics (IVD) Quality Control Products Market Report, published by Allied Market Research, forecasts that the global market was valued at $823 million in 2015, and is expected to reach $1,052 million by 2022, registering a CAGR of 3.5% during the forecast period 2016 - 2022. The quality controls products segment dominated the market with fourth-fifths share in 2015. Immunochemistry and clinical chemistry application segments together captured around half of the market share in 2015. Access Full Summary at : https://www.alliedmarketresearch.com/ivd-in-vitro-diagnostics-quality-control-product-market The IVD quality control products market is driven by factors such as increasing number of accredited laboratories, stringent mandates on the use of third party IVD quality control products, and increase in the number of IVD test volumes across the globe. 

  4. In Vitro Diagnostics (IVD) Quality Control Product Market The global In Vitro Diagnostics quality controls market is segmented on the basis of product type, application, manufacturer type, end user, and region. Based on product type, the market is segmented into quality controls, IVD quality control data management software, and quality assurance services. The quality controls segment dominated the global market by product type in 2015, and is expected to maintain its dominance by 2022, registering the fastest CAGR of 3.7% during the forecast period. This is attributed to the upsurge in demand for quality controls to validate the accuracy, precision, and reliability of IVD test results. The end users of the market include hospitals, clinical laboratories, research & academic institutes, and others. The hospital segment dominated the IVD quality controls market in 2015, and is expected to maintain its dominance during the forecast period.  

  5. In Vitro Diagnostics (IVD) Quality Control Product Market Snapshot The key players profiled in the IVD quality controls market report are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Randox Laboratories Ltd., Roche Diagnostics, Abbott Diagnostics, Helena Laboratories, Seracare Life Sciences, Inc., Technopath Clinical Diagnostics, and Sun Diagnostics, LLC. The other prominent players in the IVD quality controls industry (not profiled in the report) are Zeptometrix Corporation, ISOLAB GmbH, Sysmex Corporation, Fortress Diagnostics, Meril Life Sciences Pvt. Ltd., Multiplicom N.V., Future Diagnostics Solutions B.V., and Surmodics, Inc. 

  6. Key Benefits of In Vitro Diagnostics (IVD) Quality Control Product Market • In-depth analysis of the IVD quality controls market is based on market estimations of key segments for the period of 2014‐2022. • Comprehensive analysis of factors that drive and restrict the market growth of IVD quality controls industry is provided in the report. • Exhaustive analysis of IVD quality controls industry market segments aids in understanding the prospects of IVD quality control products that are presently in use as well as with variants that would gain prominence in the future. • Competitive intelligence of leading manufacturers and distributors helps in interpreting the competitive scenario of geographies. • The profiles and strategies of key market players are thoroughly analyzed in the report to understand the competitive outlook of the market. 

  7. In Vitro Diagnostics (IVD) Quality Control Product Market North America Europe Asia-Pacific LAMEA

  8. In Vitro Diagnostics (IVD) Quality Control Product Market Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/request-sample/1792 Follow Us On

More Related